Exicure (XCUR) Current Assets (2016 - 2026)
Exicure's (XCUR) quarterly Current Assets came in at $3.5 million in Q1 2026, down 68.76% YoY from $11.3 million in Q1 2025, and down 23.62% on a QoQ basis from $4.6 million in Q4 2025.
Exicure (XCUR) Current Assets (2016 - 2026) Analysis & Trends
Exicure (XCUR) has 11 years of Current Assets data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Current Assets fell 68.76% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (down 68.76% YoY) and the FY2025 annual result came in at $4.6 million, down 66.18% from the prior year.
- Current Assets eased to $3.5 million in Q1 2026, from $4.6 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $29.2 million in Q1 2022 to a low of $1.5 million in Q1 2024.
- A 5-year average of $9.1 million and a median of $5.4 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets slumped 87.03% — and 2025, when it jumped 672.73%.
- Tracing XCUR's Current Assets over 5 years: stood at $10.1 million in 2022, then tumbled by 79.86% to $2.0 million in 2023, then surged by 575.54% to $13.7 million in 2024, then sank by 66.18% to $4.6 million in 2025, then decreased by 23.62% to $3.5 million in 2026.
- The last three Current Assets figures came in at $3.5 million (Q1 2026), $4.6 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Exicure | 8.41 Mn | 8.41 Mn | - | 2.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 4.62 Mn |
| Sep 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 11.31 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 1.46 Mn |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 3.09 Mn |
| Jun 30, 2023 | 3.66 Mn |
| Mar 31, 2023 | 11.28 Mn |
| Dec 31, 2022 | 10.05 Mn |
| Sep 30, 2022 | 17.20 Mn |
| Jun 30, 2022 | 24.72 Mn |
| Mar 31, 2022 | 29.18 Mn |
| Dec 31, 2021 | 43.67 Mn |
| Sep 30, 2021 | 64.15 Mn |
| Jun 30, 2021 | 60.65 Mn |